Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda to Invest $30B into U.S. Operations | Contract Pharma

What are you searching for?

Sign in
Breaking News

Takeda to Invest $30B into U.S. Operations

Joins a league of pharma companies increasing investments in the U.S.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Takeda’s Cambridge, MA global hub.

Takeda is the latest major pharmaceutical company to increase its investments in the U.S. market, partly in response to President Donald Trump’s potential tariffs. The company’s CEO, Christophe Weber, announced on Thursday, during the company’s earnings call, that Takeda will be investing approximately $30 billion into its U.S. operations over the next five years.

“This reflects the fact that the U.S. is the world’s leading market for biopharmaceutical innovation, and I hope that will continue,” Weber remarked.

Other pharmaceutical companies that have announced plans to increase investments in the U.S. in anticipation of potential tariffs on the industry include Gilead, Roche, Novartis, and Johnson & Johnson. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics